The Lancet

Astrazeneca’s Experimental Drug to Treat COPD Fails to Reduce Acute Exacerbations

Astrazeneca’s Experimental Drug to Treat COPD Fails to Reduce Acute Exacerbation

On Monday, AstraZeneca PLC announced that Phase IIa study of benralizumab, an experimental drug for the treatment of Chronic Obstructive Pulmonary Disease (COPD), was published in 'The Lancet Respiratory Medicine' medical journal.

This drug is specially designed for the patients who do not respond effectively to the traditionally available inhalers. COPD is a disease related to smoking.

Location: 
Laboratories: 
Company: 

Type-2 Diabetes to Impact Two in Five Americans: Study

Type-2 Diabetes to Impact Two in Five Americans: Study

A new study has claimed that two in five American adults are likely to develop type-2 diabetes in their lifetime. Published in The Lancet medical journal, the study revealed that Hispanics and black women have even higher risk of suffering from the condition. Of them, half are expected to suffer from the disease because of sedentary lifestyle and excessive body weight.

Laboratories: 
Location: 

Obesity Trend Rising at Alarming rate in Australia and New Zealand

Obesity Trend Rising at Alarming rate in Australia and New Zealand

Obesity rates are increasing in Australia and New Zealand at an alarming rate, as per the new report published in the medical journal The Lancet. In Australia, nearly 70 percent of men are overweight and Australians have surpassed the United Kingdom in obesity rates.

In New Zealand, nearly 66 percent of adults are overweight. The rate of increase in obesity in New Zealand and Australia has surpassed all the developed nations in the world.

Laboratories: 
News: 

Obesity Problem Now Troubles All Nations across the World

Obesity Problem Now Troubles All Nations across the World

A new study published in a British medical journal has warned that obesity problem is now a major issue all over the world, with nearly 30% of the population considered fat. As per the analysis, the highest percentage of obese people resides in North America and the Middle East.

The obesity rates in China and India are also rising fast. The study that analyzed the records for 188 countries has been published in the British medical journal The Lancet.

Laboratories: 
News: 
Location: 

Exercise and Diet Control Can Reduce Diabetes Risk

Exercise and Diet Control Can Reduce Diabetes Risk

Regular Exercise and proper diet can prevent diabetes or delay its onset among high risk group as per study conducted in China. Chinese medical experts conducted Da Qing Diabetes Prevention Study for six years to conclude that diet changes can help people to delay diabetes by even 20 years. The study included both men and women and found different impact on both.

Laboratories: 
News: 
Location: 

Lab Grown Vagina Implanted Successfully

Lab Grown Vagina Implanted Successfully

Four teenage girls have been implanted laboratory grown vaginas from their own cells by medical experts in North Carolina. The girls were born with rare Mayer-Rokitansky-Kuster-Hauser (MRKH) syndrome. The syndrome impacts one in 5000 women as they are born without cervix, womb or vagina.

Food-Allergies rise among Black Children

Food-Allergies rise among Black Children

Researchers reported two times increase in number of food allergies among black children compared to the data recorded two decades earlier. As per 2013 report, the US economy faces more than $25 billion expenditure every year because of children's food allergies.

Laboratories: 
News: 
Location: 

85% of Patients not diagnosed with COPD in time

85% of Patients not diagnosed with COPD in time

A 19-year study on about 38,859 patients by UK researchers reveals that 85% of patients in the UK have not been diagnosed with chronic obstructive pulmonary disease (COPD) at early stages. The Department of Health said that early diagnosis of the disease could save the UK National Health Service by more than £1 billion over 10 years.

Location: 

OIT Treatment Proved Successful in Reducing Effect of Peanut Allergic Reactions

OIT Treatment Proved Successful in Reducing Effect of Peanut Allergic Reactions

A four to six weeks trial, termed as STOP II trial, on 99 young study subjects revealed that oral immunotherapy (OIT) can be used to lessen the effect of peanut allergic reactions, especially in children. All the participants were offered measured doses of peanut proteins, amount equal to five peanuts, with an aim to check for tolerance of their bodies for the allergen.

The findings saw that 84% to 91% of all 99 participants were able to digest 800 milligrams of peanut powder in single day, without causing any negative effects to their health.

News: 
Location: 

Vitamin D Supplements Offer Limited Benefits; New Zealand Researchers

Vitamin D Supplements Offer Limited Benefits; New Zealand Researchers

Vitamin D has been considered good for bones, stroke, heart health and general health, but a new research has not found much of positive impact of vitamin D in reducing instances of hip fractures. University of Auckland researchers analyzed 12 studies and found the impact of Vitamin D in preventing hip fractures was limited to 15 percent or even less.

News: 
Location: 

Pages

Popular Stories

Harley-Davidson to turn 8 Dyna motorbikes into new Softail bikes

Betting big on cruisers, the luxury motorcycle... Read More

Uber’s net loss declines as ride bookings grow

Uber Technologies reported lower loss by nearly 9... Read More

Samsung Galaxy Note 8 facing challenges on multiple fronts

The Samsung Galaxy Note 8 is facing an increasingly... Read More

Leaked reports reveal more about new BMW M5

Luxury carmaker BMW’s next-generation M5 car will... Read More

Tesla announces risky new approach to customer service

During the past few years, Tesla was slammed by a... Read More